For the CY 2026 OPPS, we proposed to recalibrate the APC relative payment weights for services furnished on or after January 1, 2026, and before January 1, 2027 (CY 2026), using the same basic methodology that we described in the CY 2025 OPPS/ASC final rule with comment period (89 FR 93921 through ( 93922), using CY 2024 claims data
Long-term safety and tolerability of apremilast versus placebo in psoriatic arthritis: a pooled safety analysis of three phase III, randomized, controlled trials
In addition, based on DIMAs single B-cell antibody discovery, functional membrane protein development, antibody engineering modification, and functional validation platform, the company also provides a range of custom services
Understanding how copper peptides work in your body Copper peptides don't work like typical skincare ingredients